Exchange: NASDAQ·Updated 07:29 PM EST
NMTC logo

NMTC NeuroOne Medical Technologies Corp

$0.6521
$0.0228
(3.38%)
Today
Closed $0.6521
$0.00
(0.00%)
After Hours
EarningsDec 15
Mkt Cap$5.94M
Vol98,575.00

About NMTC

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.
36

Bearish Sentiment

How do you feel about NMTC?

ZimmerBiomet
$NMTC If you want to know what DESPERATION is, it's the CLOWN 🤡 at NeuroOne IR department and Big Time Losing investors 🤡 who are using dozens of stocktwits accounts to click "Bullish" at the Sentiment meter without leaving a comment in a DESPERATE vain futile attempt to raise the Sentiment Meter, like THAT will do any good when the company OBVIOUSLY SUCKS and will soon be DELISTED.
10
MedtronicRules
$NMTC "Best Momentum Stocks to Buy for January 6th NMTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6th, 2026." GREAT CALL ZACKS, on January 6th $NMTC was OVER $5, NOW 65 CENTS. ZACKS 🤡😂🤣🤡😂🤣🤡😂🤣🤡😂🤣🤡
10
JohnStuartMill
$NMTC OH MY, IS NASDAQ DELISTING COMING SOON? The BELOW $1 current streak began on Tuesday, October 20, 2026, when the stock closed at $0.984. As of the market close on Friday, November 13, 2026, NeuroOne has closed below $1.00 for 19 consecutive business days through Friday, November 13 at $0.7559. If the stock does not close at or above $1.00 before then, the 30th consecutive business day will be Tuesday, December 1, 2026. REVERSE SPLIT WILL NOT HELP as the 1 year mark from their last reverse split is April 16, 2027. SELL NOW BEFORE IT IS TOO LATE. 😂🤣🤡😂🤣🤡😂🤣🤡😂🤣🤡😂🤣🤡😂🤣🤡😂🤣🤡 SELL NOW BEFORE IT IS TOO LATE. SELL NOW BEFORE IT IS TOO LATE.
3
8
ZimmerBiomet
$NMTC I did read that she blocked you on Nov. 10. Quote "IncognitoBull, Nov 10, back in the block list. No one here cares to watch us duke it out." Unquote. I guess you are correct, she is an unstable hypocrite, and yes, sadly it appears, also gullible, naive and easily led. I saw right through your post on Nov. 12 wondering how a stock could be "manipulated" as pure bait for her, but she fell for it hook, line and sinker, just as you expected her to. It is amusing watching her being led so easily. Shakespeare describes Incognito in Macbeth: "It is a tale told by an idiot, full of sound and fury, signifying nothing" I "wonder" if she will read your "blocked" post again and "respond" to it as you "commanded' her to? Judging by her many past hypocrisies and her seeming inability not to be so "easily led", I will judge yes, which is so very sad.
2
8
ZimmerBiomet
$NMTC The same kind of Unstable Fool Hypocrite that said: Quote "IncognitoBull, Nov 10, back in the block list. No one here cares to watch us duke it out." Unquote. It can not even be true to it's own worthless self and just shows all that it's words are meaningless.
1
8
StockShockFever
$NMTC YES, once again dim witted donkey IncognitoBull READS posts the SHE BLOCKED and the RESPONDS to them as she was COMMANDED to. QUESTION for all, what kind of unstable hypocrite FOOL ... BLOCKS a poster, and the READS the blocked posts anyway?? It is her for all to see saying "I am a cosplaying child". I will act big and tough and BLOCK posters, then I will revert to my insignificant slug self and READ all of the posts that I BLOCKED when I was cosplaying being big and tough. So Very Sad, but yet still, SO VERY AMUSING. Another gold star fot it ⭐. NOW RESPOND DONKEY. 🥕🥕🥕🥕🥕
1
8
JohnStuartMill
$NMTC IncognitoBull says: "Actions are my measure of character". YES, actions like IncognitoBull whose "difference made in the lives of others" was for many years to try to also lure them into losing investments, like MULN and SHOT and now NMTC. For info MULN is now $BINI and had an all time split adjusted high of $1,238,625,000,193,535,200.00, YES that is the actual number, and for MANY YEARS Incognito constantly posted to lure other suckers into losing their money also. SHOT is now $BNKK (Bonk altcoins), $210 to 90 cents another SCAM JOKE she constantly pushed for YEARS. 🥕🥕 Now, Waiting for the dim witted donkey to READ my post SHE BLOCKED and to respond, as led to. DO IT, read BLOCKED + RESPOND.
1
8
JohnStuartMill
$NMTC Now get ready for this company to play the same bait and switch financial tactic that they have done before, as desperate scam companies do. They will give an insider 1 million warrants at 2 cents, exercisable immediately (for a HUGE PROFIT), in exchange for putting a few thousand out of their free big salary into shares in a feeble attempt to get back above $1. MUST do something before Dec. 1st DELISTING. SELL NOW OR HOLD THE QUICKLY EMPTYING BAG.
1
8
StockShockFever
$NMTC Imagine being so Stupid, Gullible, Naive and Easily Led that they actually believe one poster on Stocktwits can "ruin" a stock. Just shows the lack of mentality. Present the carrot and the dim witted donkey follows. I thought you BLOCKED me Incognito, but the fact that you still read my posts prove what an UNSTABLE HYPOCRITE you are for all to see. BUT, good job responding as commanded to, Gold Star for you ⭐. NOW Unstable one, be a good little obedient donkey and respond to this post like you have been trained to do and prove that Pavlov's technique continues to work every time on the dim witted. DO IT, RESPOND to the carrot bait like the dullard donkey that you constantly show yourself to be. 🥕🥕🥕🥕
1
8
StockShockFever
$NMTC "IncognitoBull $NMTC StockShot & JohnStuart are the same person. He is basically admitting to being the person manipulating the stock down. He has to be right at all times.... I apologize to the investors here for having this "gent" obsessed with teaching me a lesson." What kind of Insignificant & UNSTABLE FOOL ... BLOCKS a poster, and then uses their own other account to READ their posts and then postulates their own FOOLISH and unsubstantiated conclusions all in a futile effort to alleviate their own ego shattered conscious for constantly making such FOOLISH & BIG LOSSES investment decisions like MULN, SHOT, NMTC and attempting to lure others in? NOW foolish one, be a good little obedient child and respond to this post like you have been trained to do and prove that Pavlov's technique continues to work every time on the dim witted. DO IT, RESPOND to the carrot bait like the dullard donkey that you constantly show yourself to be. 🥕🥕🥕🥕🥕🥕
1
7
MedtronicRules
$NMTC "Perhaps there is a retail whale that is shorting it, driving it down which influences others to also sell, covering at the lowered price, and playing rinse and repeat on Blue Ocean or MEMX or Sigma X2 or Citadel." YES, as expected, IncognitoBull was once again EASILY LED and fell for it, HOOK, LINE AND SINKER. YES, the lack on mental depth is just so VERY SAD.
8
MedtronicRules
$NMTC Yes John, we remember Incognito for years telling everyone that MULN and SHOT was going to make them all "Generational Wealth". What a complete joke she was. BTW, Incognito also Blocked my posts, but as the hypocrite always does, I am sure she will still read them. LIKE, what is the point of Blocking posters if she is going to read them anyway? I guess just DUH! Then to PROVE DUH, she responds for all to see and get a good laugh.
8
annomymous
$NMTC can’t be a great sign they gave up on Stocktwits posting, unless they learned that is complete insanity. The risk reward is pretty good here for those that haven’t gotten in already.. trading at .7x sales with fda approved product? Even a buyout at $20 million is a 3x bagger here. Might buy a couple more. Better odds than lottery tickets
6
NeuroOne_IR
$NMTC Our OneRF® Trigeminal Nerve Ablation System brings stimulation, mapping and radiofrequency ablation into a multi-contact probe—innovation we’re proud to bring to neurological care. Conventional single-tip systems typically require repositioning to map and treat different trigeminal nerve distributions. Our probe lets physicians work across multiple contacts along a single fixed trajectory. In the initial 15-patient series published in Pain Management, contact-level mapping was achieved in every case, without probe repositioning to map and treat multiple distributions. Seeing this core capability documented in clinical use is an encouraging step for OneRF. Potential benefits for procedure time, anesthesia cycles and patient comfort, along with long-term outcomes, require further evaluation.
4
IncognitoBull
$NMTC do they get paid too much? Probably. Imagine taking a job where you're not guaranteed success, you're not guaranteed FDA approval, you might have to start over....at the age of what 60? Rosa is no spring chicken. I am close to his age too...lil younger, I wouldn't risk my career on the unknown. Anyway, yeah, the SP sucks. Still here. No f's given.
4
NeuroOne_IR
$NMTC Today we announced initial clinical results with our OneRF® Trigeminal Nerve Ablation System, published in the peer-reviewed journal Pain Management. The retrospective study evaluated 15 patients with trigeminal neuralgia inadequately controlled by medication: • 14 of 15 (93.3%) were pain-free immediately; the remaining patient became pain-free approximately one week later. • All 15 achieved favorable outcomes at their last follow-up, with a mean follow-up of six months. • Eight (53.3%) were pain-free without medication; six were pain-free while continuing medication, and one had residual pain controlled with medication at their last follow-up. Our multi-contact probe enabled mapping and treatment of multiple trigeminal nerve distributions along a fixed trajectory, without probe repositioning. These encouraging findings strengthen the evidence behind OneRF. Larger studies with comparison groups and longer follow-up are needed to assess durability and comparative effectiveness.
4
MarianneV
$NMTC So why is a company with advanced, commercialized medical tech trading at these depressed levels? It comes down to structural Wall Street mechanics, not the underlying science. * The Wall Street Ban: Institutional funds are legally blocked from buying stocks under $5.00 or micro-caps under $100M. They literally cannot buy this yet. * Low Volume Trap: Low daily trading volume means big funds can't enter or exit positions without completely distorting the stock price. * Short-Term Noise: High-frequency algorithms and short-sellers exploit the low liquidity, while the market obsessively focuses on short-term cash burn rather than the multi-billion dollar long-term pipeline. The Bottom Line: The tech is validated, FDA-approved, and commercializing. For investors acting like venture capitalists, $NMTC offers asymmetric upside if you can look past the daily algorithmic noise.
1
MarianneV
$NMTC “When a technology alters the standard of care so profoundly that the old way of doing things becomes unthinkable, the eventual acquisition isn't valued by current sales metrics. It is priced as a multi-billion-dollar tollbooth on the future of neurology and spine care. The giants will pay an absolute king's ransom to own that tollbooth.”
3
pufferfishcapital
$NMTC Since NeuroOne began publicly trading on August 4, 2017, at a split-adjusted price of $76.50, the stock has declined to $0.86 as of October 2026.This represents a total stock performance decline of 98.88% over the current CEO's tenure. He is paid $787K while the CFO gets $405K and the CTO $333K . For an 18 person company, given the cash burn and the historical stock performance, it really is egregious that top management gorges while shareholders bleed. I bought a small position late last year, which is now a tiny tiny position due to the decline this year. I blame myself , not management, because the info was publicly available and I should have passed given this, but it still boggles me that 1) there seems no pressure from the board or any institutional investors to replace top maangement, lower cash burn (inc salaries), and close deals w partners , and if all else fails, sell the company
2
MarianneV
$NMTC “The "Tuck-In" Acquisition Model: Large medical device companies rarely invent everything internally. Instead, they let micro-cap or small-cap innovators do the high-risk engineering and early clinical trials. Once the technology achieves FDA 510(k) clearances (which NeuroOne has done across multiple product lines), a major player can easily "tuck" that product into their global distribution network.”
2

Advertisement|Remove ads.